Robert Blum | Investor Relations |
Jan D'Alvise | President and Chief Executive Officer |
Brian Ford | Chief Financial Officer |
Monique Champagne | Vice President, Clinical Affairs |
Leland Gershell | Oppenheimer |
Good day, and welcome to the Acasti Pharma Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Robert Blum of Lytham Partners.